L Lisata Therapeutics
L
Uždarymo kaina
3.45 -0.58
Apžvalga
Akcijų kainos pasikeitimas
24 val.
Min
3.43
Max
3.51
Pajamos | -1.5M -4.5M |
|---|---|
Pelno marža | -2,954 |
Darbuotojai | 21 |
Kitas uždarbis | 2026-08-06 |
|---|
Rinkos kapitalizacija | 2.7M 26M |
|---|---|
Ankstesnė atidarymo kaina | 4.03 |
Ankstesnė uždarymo kaina | 3.45 |
Lisata Therapeutics Grafikas
Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.
Apie bendrovę Lisata Therapeutics
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
